Colilen IBS is an innovative product for the treatment of irritable bowel syndrome (IBS), a condition which manifests itself with varying intensity through a number of symptoms that vary from person to person.
INDICATIONS
Colilen IBS is indicated for the treatment of irritable bowel syndrome, characterized by abdominal pain, bloating, distension and discomfort, whether or not associated with variations in stool appearance and bowel irregularity (constipation, diarrhea or alternation of the two).
Thanks to its protective mechanism, Colilen IBS gradually reduces intestinal disorders and, depending on the intensity of the disorder, it is advisable to follow the treatment for 2 to 6 weeks and to repeat it as soon as the first symptoms reappear.
HOW DOES IT WORK?
Colilen IBS capsules work thanks to its patented molecular complex (IT n° 102012902020829) ActiMucin, composed of Resins, Polysaccharides and Polyphenols. Through a mechanical and physical mechanism, ActiMucin interacts with the surface of the intestinal mucosa, forming a protective film that shields the mucosa from contact with irritating substances.